Radicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis
- 1 September 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 241 (2-3) , 221-227
- https://doi.org/10.1016/0014-2999(93)90206-w
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 26 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cellsAnti-Cancer Drugs, 1992
- Angiogenesis inhibition suppresses collagen arthritis.The Journal of Experimental Medicine, 1992
- Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitorBiochemical and Biophysical Research Communications, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Medroxyprogesterone acetate, an anti‐cancer and anti‐angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cellsInternational Journal of Cancer, 1989
- A highly potent antiangiogenic activity of retinoidsCancer Letters, 1989
- Angiogenic activity of rat mammary carcinomas induced by 7, 12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibitionCancer Letters, 1988
- Functional studies of newly synthesized benzoic acid derivatives: Identification of highly potent retinoid-like activityJournal of Cellular Physiology, 1988
- Angiogenic FactorsScience, 1987